In the setting of gut microbiota and diabetes, GLP-1 is thought to play a role in reducing appetite, fat mass, and hepatic insulin resistance (52), while GLP-2 is believed to reduce metabolic endotoxemia by decreasing intestinal wall permeability (57). This evidence concerns the gene GCG and diabetes mellitus.